Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:OHRP

OHR Pharmaceutical (OHRP) Stock Price, News & Analysis

OHR Pharmaceutical logo

About OHR Pharmaceutical Stock (NASDAQ:OHRP)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
$5.39
$9.07
52-Week Range
N/A
Volume
N/A
Average Volume
180,228 shs
Market Capitalization
$1.08 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive OHRP Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for OHR Pharmaceutical and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

OHRP Stock News Headlines

Pharmaceutical Stocks
CYCC Cyclacel Pharmaceuticals, Inc.
The End of Elon Musk…?
The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, and he's been proven right time and time again. And now, while the media focuses on Tesla's "demise," he's uncovered an AI breakthrough that's about to make Elon's doubters eat their words yet again. According to his research, if you listen to the media and miss out on Elon's newest breakthrough, it's going to cost you the fortune of a lifetime.tc pixel
OHR Pharmaceutical (OHRP) is now in Oversold Territory
See More Headlines

OHRP Stock Analysis - Frequently Asked Questions

OHR Pharmaceutical Inc (NASDAQ:OHRP) posted its quarterly earnings data on Tuesday, August, 14th. The biotechnology company reported ($0.20) earnings per share (EPS) for the quarter.

Shares of OHR Pharmaceutical reverse split on Monday, February 4th 2019.The 1-20 reverse split was announced on Wednesday, January 23rd 2019. The number of shares owned by shareholders was adjusted after the closing bell on Friday, February 1st 2019. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split.

Based on aggregate information from My MarketBeat watchlists, some other companies that OHR Pharmaceutical investors own include Actinium Pharmaceuticals (ATNM), TherapeuticsMD (TXMD), IVERIC bio (OPHT), Cytori Therapeutics (CYTX), Novavax (NVAX), Immunomedics (IMMU) and Synergy Pharmaceuticals (SGYP).

Company Calendar

Last Earnings
8/14/2018
Today
8/29/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical Preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:OHRP
CIK
1173281
Fax
N/A
Employees
3
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$13.23 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-75.46%
Return on Assets
-71.18%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
3.73
Quick Ratio
3.73

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$3.86 per share
Price / Book
N/A

Miscellaneous

Outstanding Shares
2,829,000
Free Float
N/A
Market Cap
$1.08 million
Optionable
Not Optionable
Beta
0.84
Options Trading Made Easy - Download Now Cover

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report

This page (NASDAQ:OHRP) was last updated on 8/30/2025 by MarketBeat.com Staff
From Our Partners